Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- NYR.AU
- Price
- 0.09
- Stock movement down
- -0.01 (-5.56%)
- Company name
- Nyrada Inc
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 19.67M
- Ent value
- 15.75M
- Price/Sales
- 6.21
- Price/Book
- 3.89
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -25.65%
- 1 year return
- -28.08%
- 3 year return
- -21.73%
- 5 year return
- -9.02%
- 10 year return
- -
Last updated: 2025-04-05
DIVIDENDS
NYR.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 6.21 |
| Price to Book | 3.89 |
| EV to Sales | 4.97 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 210.33M |
| EPS (TTM) | -0.06 |
| FCF per share (TTM) | -0.06 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 3.17M |
| Gross profit (TTM) | 1.06M |
| Operating income (TTM) | -12.55M |
| Net income (TTM) | -9.11M |
| EPS (TTM) | -0.06 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 33.29% |
| Operating margin (TTM) | -396.13% |
| Profit margin (TTM) | -287.32% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 4.77M |
| Net receivables | 1.02M |
| Total current assets | 5.87M |
| Goodwill | 0.00 |
| Intangible assets | 31.32K |
| Property, plant and equipment | 1.59K |
| Total assets | 5.91M |
| Accounts payable | 118.46K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 835.60K |
| Total liabilities | 855.63K |
| Shareholder's equity | 5.05M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -9.20M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -9.20M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -180.24% |
| Return on Assets | -154.14% |
| Return on Invested Capital | -180.24% |
| Cash Return on Invested Capital | -182.06% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.10 |
| Daily high | 0.10 |
| Daily low | 0.09 |
| Daily Volume | 524K |
| All-time high | 0.45 |
| 1y analyst estimate | - |
| Beta | 1.09 |
| EPS (TTM) | -0.06 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NYR.AU | S&P500 | |
| Current price drop from All-time high | -78.99% | -17.56% |
| Highest price drop | -95.96% | -56.47% |
| Date of highest drop | 20 Feb 2024 | 9 Mar 2009 |
| Avg drop from high | -58.69% | -11.07% |
| Avg time to new high | 94 days | 12 days |
| Max time to new high | 1062 days | 1805 days |
COMPANY DETAILS
Marketcap
19.67M
Marketcap category
Small-cap
Description
Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases. Its develops oral Proprotein Convertase Subtilisin/Kexin Type 9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; and neuroprotectant drug to reduce long-term disability in patients with traumatic brain injury and ischaemic stroke. Nyrada Inc. was incorporated in 2017 and is based in Sydney, Australia.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found